CAPLIPOINT.NS Balance Sheet
Caplin Point Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:40
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹267.01 Cr. | ₹438.62 Cr. | ₹530.32 Cr. | ₹547.49 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹220.48 Cr. | ₹116.62 Cr. | ₹139.22 Cr. | ₹208.62 Cr. | CapitalWorkInProgress |
| Goodwill | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | Goodwill |
| Other Intangible Assets | ₹10.94 Cr. | ₹12.52 Cr. | ₹11.27 Cr. | ₹32.52 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹70.52 Cr. | ₹137.63 Cr. | ₹279.13 Cr. | ₹473.31 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹49.71 Cr. | ₹74.96 Cr. | ₹110.41 Cr. | ₹136.55 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹636.94 Cr. | ₹805.16 Cr. | ₹1,074.63 Cr. | ₹1,459.82 Cr. | NoncurrentAssets |
| Inventories | ₹288.22 Cr. | ₹363.04 Cr. | ₹336.10 Cr. | ₹428.86 Cr. | Inventories |
| Trade Receivables | ₹394.06 Cr. | ₹542.72 Cr. | ₹632.49 Cr. | ₹825.81 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹177.56 Cr. | ₹138.70 Cr. | ₹199.45 Cr. | ₹94.18 Cr. | CashAndCashEquivalents |
| Current Investments | ₹159.17 Cr. | ₹237.98 Cr. | ₹311.33 Cr. | ₹385.71 Cr. | CurrentInvestments |
| Other Current Assets | ₹147.60 Cr. | ₹150.19 Cr. | ₹205.25 Cr. | ₹250.07 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹1,554.46 Cr. | ₹1,892.21 Cr. | ₹2,133.95 Cr. | ₹2,585.66 Cr. | CurrentAssets |
| Total Assets | ₹2,191.40 Cr. | ₹2,697.37 Cr. | ₹3,208.58 Cr. | ₹4,045.48 Cr. | Assets |
| Equity Share Capital | ₹15.18 Cr. | ₹15.19 Cr. | ₹15.20 Cr. | ₹15.20 Cr. | EquityShareCapital |
| Other Equity | ₹1,865.30 Cr. | ₹2,300.51 Cr. | ₹2,835.29 Cr. | ₹3,571.22 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹1,880.48 Cr. | ₹2,315.70 Cr. | ₹2,850.49 Cr. | ₹3,586.42 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹26.79 Cr. | ₹31.12 Cr. | ₹35.90 Cr. | ₹44.38 Cr. | NonControllingInterest |
| Total Equity | ₹1,907.27 Cr. | ₹2,346.82 Cr. | ₹2,886.39 Cr. | ₹3,630.80 Cr. | Equity |
| Long-term Borrowings | ₹0.00 Cr. | ₹0.92 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹16.13 Cr. | ₹20.00 Cr. | ₹15.81 Cr. | ₹28.74 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹3.41 Cr. | ₹0.28 Cr. | ₹0.55 Cr. | ₹0.57 Cr. | BorrowingsCurrent |
| Trade Payables | ₹164.37 Cr. | ₹209.42 Cr. | ₹217.58 Cr. | ₹296.03 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹27.45 Cr. | ₹35.61 Cr. | ₹19.00 Cr. | ₹16.58 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹268.00 Cr. | ₹330.55 Cr. | ₹306.38 Cr. | ₹385.94 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹2,191.40 Cr. | ₹2,697.37 Cr. | ₹3,208.58 Cr. | ₹4,045.48 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from CAPLIPOINT.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).